Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Eclinicalmedicine|December 2, 2022
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancerToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2026
Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025Beyhan Ataseven, Marco Battista, Matthias W Beckmann, et al.
Breast Care (Basel, Switzerland)|February 26, 2019
Validation of a Nomogram Predicting Non-Sentinel Lymph Node Metastases among Patients with Breast Cancer after Primary Systemic Therapy - a transSENTINA SubstudyCornelia Liedtke, Dennis Görlich, Ingo Bauerfeind, et al.
Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.
Cancers|January 11, 2022
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment MonitoringElena Ioana Braicu, Andreas du Bois, Jalid Sehouli, et al.
Annals of Surgical Oncology|August 3, 2018
Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking SurgeryBeyhan Ataseven, Teresa González Luengo, Andreas du Bois, et al.
Breast (Edinburgh, Scotland)|November 28, 2016
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trialLukas Schwentner, Gisela Helms, Valentina Nekljudova, et al.
Gynecologic Oncology|November 10, 2020
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?Nicolò Bizzarri, Andreas du Bois, Robert Fruscio, et al.
Plos One|October 12, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancerAntonia Sophie Wenners, Keyur Mehta, Sibylle Loibl, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2023
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrenceHelmut Plett, Enzo Ricciardi, Vlad Vacaru, et al.
Pageof 11